Literature DB >> 26350908

Psychedelic medicine: a re-emerging therapeutic paradigm.

Kenneth W Tupper1, Evan Wood2, Richard Yensen1, Matthew W Johnson1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26350908      PMCID： PMC4592297          DOI： 10.1503/cmaj.141124

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  34 in total

1.  Use of d-lysergic acid diethylamide in the treatment of alcoholism.

Authors:  N CHWELOS; D B BLEWETT; C M SMITH; A HOFFER
Journal:  Q J Stud Alcohol       Date:  1959-09

Review 2.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

3.  Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.

Authors:  Jürgen Rehm; Colin Mathers; Svetlana Popova; Montarat Thavorncharoensap; Yot Teerawattananon; Jayadeep Patra
Journal:  Lancet       Date:  2009-06-27       Impact factor: 79.321

4.  Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

Authors:  José Carlos Bouso; Fernanda Palhano-Fontes; Antoni Rodríguez-Fornells; Sidarta Ribeiro; Rafael Sanches; José Alexandre S Crippa; Jaime E C Hallak; Draulio B de Araujo; Jordi Riba
Journal:  Eur Neuropsychopharmacol       Date:  2015-01-16       Impact factor: 4.600

Review 5.  Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.

Authors:  D E Nichols
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

6.  Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

Authors:  C S Grob; D J McKenna; J C Callaway; G S Brito; E S Neves; G Oberlaender; O L Saide; E Labigalini; C Tacla; C T Miranda; R J Strassman; K B Boone
Journal:  J Nerv Ment Dis       Date:  1996-02       Impact factor: 2.254

Review 7.  Hallucinogen persisting perception disorder: what do we know after 50 years?

Authors:  John H Halpern; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2003-03-01       Impact factor: 4.492

8.  Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.

Authors:  John H Halpern; Andrea R Sherwood; Torsten Passie; Kimberly C Blackwell; A James Ruttenber
Journal:  Med Sci Monit       Date:  2008-08

9.  MDA-assisted psychotherapy with neurotic outpatients: a pilot study.

Authors:  R Yensen; F B Di Leo; J C Rhead; W A Richards; R A Soskin; B Turek; A A Kurland
Journal:  J Nerv Ment Dis       Date:  1976-10       Impact factor: 2.254

Review 10.  Hallucinogens.

Authors:  David E Nichols
Journal:  Pharmacol Ther       Date:  2004-02       Impact factor: 12.310
View more
  28 in total

1.  Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.

Authors:  Wm Jeptha Davenport
Journal:  CMAJ       Date:  2016-02-16       Impact factor: 8.262

2.  Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Authors:  Benjamin J Malcolm; Kelly C Lee
Journal:  Ment Health Clin       Date:  2018-03-23

Review 3.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 4.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

5.  Psychedelics for psychological and existential distress in palliative and cancer care.

Authors:  D Rosenbaum; A B Boyle; A M Rosenblum; S Ziai; M R Chasen; MPhil Pall Med
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 6.  Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Authors:  Sam G Moreton; Luke Szalla; Rachel E Menzies; Andrew F Arena
Journal:  Psychopharmacology (Berl)       Date:  2019-11-29       Impact factor: 4.530

7.  An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders.

Authors:  Marika Renelli; Jenna Fletcher; Kenneth W Tupper; Natasha Files; Anya Loizaga-Velder; Adele Lafrance
Journal:  Eat Weight Disord       Date:  2018-11-24       Impact factor: 4.652

8.  Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.

Authors:  Laurie Cloutier-Gill; Evan Wood; Trevor Millar; Caroline Ferris; M Eugenia Socias
Journal:  J Psychoactive Drugs       Date:  2016-05-18

9.  The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.

Authors:  Elena Argento; Melissa Braschel; Zach Walsh; M Eugenia Socias; Kate Shannon
Journal:  J Psychopharmacol       Date:  2018-09-26       Impact factor: 4.153

10.  Association between posttraumatic stress disorder and nonfatal drug overdose.

Authors:  William K Lee; Kanna Hayashi; Kora DeBeck; M J S Milloy; Cameron Grant; Evan Wood; Thomas Kerr
Journal:  Psychol Trauma       Date:  2019-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.